Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: VA NONMETROPOLITAN AREA — October 2026
Nonmetro Virginia pays up for scarce clinical and manufacturing talent.
CRA pay in Virginia's nonmetro area hit $99,517 against a national median of $90,065, while Regulatory Affairs Specialist pay fell to $97,331 even as the role stays among the hardest to fill nationally.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Rural VA labor force decline: -68,000 — Since early 2025, via retirement/out-migration
- VA unemployment rate: 3.6% — vs 4.1% national rate, Sept 2026
- VA professional services job losses: -9,500 — End of 2025 through June 2026
- CRA advertised pay premium: $99,517 metro vs $90,065 national — Metro exceeds national by ~10.5%
Key takeaways
Validation Engineer pay is pulling ahead of the national rate.
Metro advertised pay of $112,320 now exceeds the national median of $106,478, a reversal that tracks with new manufacturing investment signals like Eli Lilly's Virginia plant. Organizations competing for bioprocess and automation talent should expect this premium to hold as build-out hiring ramps.
Regulatory affairs pay is falling even as the role stays hard to fill.
Metro advertised pay for Regulatory Affairs Specialists dropped significantly to $97,331 even as national data identifies regulatory affairs among the hardest pharma roles to fill in 2026. Falling advertised pay alongside persistent vacancy risk may reflect employers downshifting role scope or seniority; this is worth testing before assuming the role has become easier to staff.
Clinical Research Associate pay is diverging sharply from the national trend.
Metro CRA pay of $99,517 sits well above the national median of $90,065, an unusual premium for a nonmetro market and consistent with national reporting that experienced CRAs remain the bottleneck, with entry-level hires easier to source. This premium directly affects the economics of insourcing clinical operations versus relying on CRO capacity that is itself constrained by Virginia's professional services contraction.
Outsourcing math is getting harder.
Virginia's professional services sector lost 9,500 jobs through June 2026, a pool that normally supplies contract regulatory and clinical staffing capacity to life sci operators. Thinner CRO and consulting capacity statewide may push build-vs-outsource decisions back toward internal hires even where advertised pay has risen.
Median advertised pay by role — VA NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $77,500 | $115,544 | $131,153 | Significant increase | $130,339 |
| Clinical Research Associate | $64,430 | $99,517 | $111,099 | Significant increase | $90,065 |
| Lab Technician | $39,815 | $42,206 | $52,000 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $72,885 | $97,331 | $110,674 | Significant decline | $103,780 |
| Clinical Data Manager | $97,257 | $103,064 | $120,049 | Significant decline | $123,653 |
| Biostatistician | $108,887 | $145,324 | $164,240 | Stable | $131,958 |
| Validation Engineer * | $90,422 | $112,320 | $165,360 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Rural Virginia's labor force has contracted by roughly 68,000 people since early 2025 through retirement and out-migration, compounding structural talent scarcity even as statewide unemployment holds at a comparatively tight 3.6%. Professional services employment losses of 9,500 jobs across the state between late 2025 and June 2026 are thinning the pool of regulatory, consulting, and contract research capacity that nonmetro life sci operations typically draw on.
What it means
Shrinking rural labor supply combined with professional services contraction means build-vs-outsource tradeoffs now carry more execution risk — CRO and regulatory consulting bench strength is tightening at the same time internal recruiting pools shrink. Eli Lilly's 300+ job manufacturing build in Virginia signals that credentialed biomanufacturing and validation talent will face new in-state competition for the first time in years. Consider reviewing retention terms for validation engineering and quality roles now, ahead of manufacturing expansion drawing talent toward higher-profile employers.
Looking ahead
Early indicator: Watch whether Eli Lilly's Virginia manufacturing build generates visible wage pressure on Validation Engineer and bioprocess roles in adjacent nonmetro counties over the next two quarters.
Emerging pressure point: Rural out-migration of roughly 68,000 people statewide since early 2025 may accelerate age-related attrition in quality and manufacturing functions, where nearly a quarter of the national life sci workforce is already 55 or older.
Worth watching: Monitor whether falling Regulatory Affairs and Clinical Data Manager advertised pay reflects an actual easing of demand or a shift toward lower-seniority postings, which would understate true hiring difficulty.
Potential inflection point: Continued professional services job losses statewide could further constrain CRO and regulatory consulting capacity available to nonmetro life sci employers, raising the relative cost of outsourcing clinical and regulatory functions.
Sources
- Weldon Cooper Center for Public Service — Virginia rural labor force decline of ~68,000 since early 2025
- Virginia Works — Professional services job losses of 9,500 statewide
- Virginia Works / state economic development reporting — Eli Lilly Virginia plant to add 300+ manufacturing jobs
- BioSpace — Regulatory affairs among hardest-to-fill pharma roles in 2026
- Industry life sciences labor market research — Experienced CRAs remain the primary talent bottleneck
- Virginia Works / Bureau of Labor Statistics — Virginia unemployment rate held at 3.6% in September 2026
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.